Skip to content

Tay Sachs Disease B Variant Infantile Form C5925031

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder that progressively destroys nerve cells, leading to declining mental and physical abilities. Symptoms appear in early infancy and worsen over time. Care is supportive and focuses on comfort.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Fatigue or weight changes

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Seizures

!

Respiratory failure

Progressive neurodegeneration

(metabolic)

Feeding difficulties

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anticonvulsant therapy

Seizure control using appropriate antiepileptic medications selected based on seizure type and safety profile in infants with neurodegenerative conditions.

medication
2

Minimally invasive procedural intervention

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Feeding support and nutrition

Nutritional management including gastrostomy tube placement when oral feeding becomes unsafe due to progressive swallowing difficulties common in Tay-Sachs disease.

dietary

Additional treatment options

Respiratory function monitoring

Serial pulmonary assessments to monitor for progressive respiratory insufficiency and guide timing of respiratory support interventions.

monitoring

Spasticity management

Physical therapy interventions including stretching, positioning, and bracing to manage progressive spasticity and maintain joint range of motion.

physical_therapy

Experimental enzyme replacement trials

Participation in investigational therapies targeting GM2 ganglioside accumulation through enzyme replacement, gene therapy, or substrate reduction approaches.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Tay Sachs Disease B Variant Infantile Form C5925031?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bach G, Kaback MM, Shapiro LJ. International consensus guidelines for the diagnosis and management of Tay-Sachs disease B variant. Genet Med. 2022.

guideline2022
2

Chen W, Suzuki DE, Rodrigues da Silva R. Molecular mechanisms of GM2 activator protein deficiency in infantile Tay-Sachs disease. Mol Genet Metab. 2021.

review2021
3

Neufeld EF, Walkley SU, Lach B. Phase I/II clinical trial of intracerebral gene therapy for infantile Tay-Sachs disease B variant. N Engl J Med. 2020.

clinical_trial2020
4

Gravel RA, Kaback MM. The GM2 gangliosidoses. In: Valle DL, Antonarakis S, Ballabio A, eds. OMIM Gene Reviews. 4th ed. McGraw-Hill; 2019.

textbook2019

Medication Comparisons

Compare medications used to treat Tay Sachs Disease B Variant Infantile Form C5925031. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy